venous-thromboembolism

Documents about venous-thromboembolism

• : Pharmacokinetics of Enoxaparin After Coronary Artery Bypass Graft Surgery#812680ClinicalTrials.gov
• The use of clot waveform analysis as an additional parameter for venous thromboembolism risk assessment in patient with prolonged immobilization#977776USM Repository
• The risk of venous thromboembolism in kidney transplant recipients is enhanced following a cytomegalovirus infection#257482HAL (France)
• Multi-Center Human Alert Trial to Prevent DVT and PE#833046ClinicalTrials.gov
• Warfarin Patient Self-management Implementation in the US Healthcare System#967620ClinicalTrials.gov
• Blood pressure and risk of venous thromboembolism: a cohort analysis of 5.5 million UK adults and Mendelian randomization studies#474064Spiral
• The Correlation of a D-dimer Testing Protocol With Venous Thromboembolism in Surgical Colorectal Patients#804791ClinicalTrials.gov
• Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)#864041ClinicalTrials.gov
• Content Quality, Reliability, and Factors Associated With Likes of Venous Thromboembolism-Related Short Videos on TikTok and Bilibili: A Cross-Platform Analysis.#645602NCBI PubMed Central
• An Evaluation of Clotting Factor Activity Before and After Total Hip Arthroplasty#803362ClinicalTrials.gov
• A Clinical Trial Comparing Efficacy and Safety of Dabigatran Etexilate With Warfarin in Patients With Cerebral Venous and Dural Sinus Thrombosis (RE-SPECT CVT)#849801ClinicalTrials.gov
• Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma#981075ClinicalTrials.gov
• Construction of a Follow-up Evaluation Index System for Patients with Venous Thromboembolism Based on the Donabedian Model: A Modified Delphi Study.#1054336NCBI PubMed Central
• Development and validation of a predictive model for perioperative venous thromboembolism in colorectal cancer patients based on D-dimer combined with fibrinogen levels.#368064NCBI PubMed Central
• Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis#862783ClinicalTrials.gov
• Knowledge, attitude and practice of venous thromboembolism prophylaxis among doctors and nurses in a tertiary teaching Hospital in Kelantan#190828USM Repository
• Rate and risk factors of venous thromboembolism during neoadjuvant chemotherapy for advanced ovarian cancer: a retrospective analysis from a referral center#445714IRIS
• Incidence of Intracranial Hemorrhage in Glioma Patients With Venous Thromboembolism Converted From LMWH to Apixaban#810273ClinicalTrials.gov
• ODEN Trial: Option vs. Denali IVC Filters#832763ClinicalTrials.gov
• Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters#835423ClinicalTrials.gov
• Vascular Boot Warming Program After Acute Deep Vein Thrombosis (DVT) ± Pulmonary Embolism (PE)#904012ClinicalTrials.gov
• Evaluating the Hemodynamic Performance of the VenAir Sequential Compression System#992964ClinicalTrials.gov
• Primary Thromboprophylaxis in Pancreatic Cancer Patients: Why Clinical Practice Guidelines Should Be Implemented#179477HAL (France)
• Construction and validation of a machine learning-based risk prediction model for venous thromboembolism in older adult patients: A multifactorial analysis of 28,231 cases.#388725NCBI PubMed Central
• In Situ Alteplase for Rescue Recanalization After Glenn Thrombosis#476091HAL (France)
• SAVES-IBD: Safety & Efficacy of Aspirin vs. Standard of Care for VTE Prophylaxis After IBD Surgery#857421ClinicalTrials.gov
• The OAT Trail: The Obesity Anti-Coagulation Thromboprophylaxis Trial.#892489ClinicalTrials.gov
• CoMbination of Data From European Cohorts as Part of the European MORPHEUS Project [HORIZON-HLTH-2022-11-01] - "MC-MORPHEUS".#908280ClinicalTrials.gov
• Molecular Investigation of Genetic Factors in CArDiovascular Diseases Using an BIOresource of Healthy Volunteers#865424ClinicalTrials.gov
• Risk prediction of combined fibrinogen degradation products, thrombomodulin, and maximum amplitude for assessing association with venous thromboembolism in patients with post-traumatic fractures#130383Unpaywall
• Real-life Clinical Outcomes of Direct Oral Anticoagulants (MACACOD)#826820ClinicalTrials.gov
• Rivaroxaban vs Enoxaparin After Cesarean Section: Laboratory Thromboprophylaxis Outcomes#834495ClinicalTrials.gov
• Risk prediction of combined fibrinogen degradation products, thrombomodulin, and maximum amplitude for assessing association with venous thromboembolism in patients with post-traumatic fractures#126101PLOS
• Assessing Feasibility of Thromboprophylaxis With Apixaban in JAK2-positive Myeloproliferative Neoplasm Patients#875294ClinicalTrials.gov
• Safety Study of Stopping Thromboprophylaxis Based on Ultrasound Results After Total Knee Replacement#884967ClinicalTrials.gov
• Endovascular treatment of iliofemoral deep vein thrombosis in pregnancy using US-guided percutaneous aspiration thrombectomy#955018Koc University Digital Collections
• Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism#983827HAL (France)
• D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months#1008086ClinicalTrials.gov
• Prevention of venous thromboembolism after total hip and knee arthroplasties in Australian hospitals: what are we using?#393452ResearchOnline@ND
• Antepartum and postpartum thromboprophylaxis: A survey of current practices in South Africa and comparison with recommendations#429109WIReDSpace
• Extended Prophylactic Anticoagulation Following Spinal Surgery for Metastatic Disease#853387ClinicalTrials.gov
• Physical Activity in Children at Risk of Post-thrombotic Sequelae (PACT)#911514ClinicalTrials.gov
• Safety and Efficacy of Lean Body Weight-based IV Heparin Dosing in Obese/Morbidly Obese Patients#867119ClinicalTrials.gov
• A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 Pandemic#853599ClinicalTrials.gov
• Venous thromboembolism with combined oral contraceptives based on estrogen and progestin content: a disproportionality analysis of the United States Food and Drug Administration Adverse Event Reporting System database#159210HAL (France)
• Morbimortalidade, desfechos hospitalares e impacto econômico do tromboembolismo venoso no Brasil: uma análise de tendência temporal (2000-2024)#412972Repositório Institucional da Universidade Federal de Sergipe
• RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing#807433ClinicalTrials.gov
• The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE)#856379ClinicalTrials.gov
• An Observational Study to Learn More About How Safe Rivaroxaban is And How Well it Works in Children With Congenital Heart Disease Who Had a Heart Surgery Called the Fontan Procedure#806712ClinicalTrials.gov
• Role of Constitutive Endothelial Dysfunction in the Pathogenesis of Unprovoked Venous Thromboembolism: Characterization of Endothelial Colony-Forming Cells and Association with Risk of Recurrence#478765IRIS